XML 18 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2023 $ 1,510,900,000 $ 103,800,000 $ 1,444,100,000 $ (37,000,000.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cash dividends paid on common stock (75,100,000)   (75,100,000)  
Issuance of common stock under stock-based compensation plans 1,900,000 300,000 1,600,000  
Stock-based compensation expense 15,300,000   15,300,000  
Repurchase of common stock (12,500,000) (100,000) (12,400,000)  
Other comprehensive income (loss) 1,200,000     1,200,000
Net earnings (loss) 209,700,000   209,700,000  
Balance at end of period at May. 03, 2024 1,651,400,000 104,000,000.0 1,583,200,000 (35,800,000)
Balance at beginning of period at Feb. 02, 2024 1,547,900,000 104,000,000.0 1,478,900,000 (35,000,000.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cash dividends paid on common stock (37,500,000)   (37,500,000)  
Issuance of common stock under stock-based compensation plans 400,000 100,000 300,000  
Stock-based compensation expense 6,900,000   6,900,000  
Repurchase of common stock (10,300,000) (100,000) (10,200,000)  
Other comprehensive income (loss) (800,000)     (800,000)
Net earnings (loss) 144,800,000   144,800,000  
Balance at end of period at May. 03, 2024 1,651,400,000 104,000,000.0 1,583,200,000 (35,800,000)
Balance at beginning of period at Oct. 31, 2024 1,551,900,000 101,500,000 1,496,400,000 (46,000,000.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cash dividends paid on common stock (76,300,000)   (76,300,000)  
Issuance of common stock under stock-based compensation plans 1,300,000   1,300,000  
Stock-based compensation expense 9,800,000   9,800,000  
Repurchase of common stock (203,700,000) (2,500,000) (201,200,000)  
Other comprehensive income (loss) 4,000,000.0     4,000,000.0
Net earnings (loss) 189,600,000   189,600,000  
Balance at end of period at May. 02, 2025 1,476,600,000 99,000,000.0 1,419,600,000 (42,000,000.0)
Balance at beginning of period at Jan. 31, 2025 1,467,600,000 100,300,000 1,414,500,000 (47,200,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cash dividends paid on common stock (37,800,000)   (37,800,000)  
Issuance of common stock under stock-based compensation plans 600,000   600,000  
Stock-based compensation expense 5,400,000   5,400,000  
Repurchase of common stock (101,200,000) (1,300,000) (99,900,000)  
Other comprehensive income (loss) 5,200,000     5,200,000
Net earnings (loss) 136,800,000   136,800,000  
Balance at end of period at May. 02, 2025 $ 1,476,600,000 $ 99,000,000.0 $ 1,419,600,000 $ (42,000,000.0)